Evidence map›Paper›PMID 39640493›Full record

ArticleFrontiers in transplantation2024

Quality of life, anxiety, and depression improve at one-year after liver transplantation in patients with advanced liver disease.

Rosana Cordoba-Alvarado, Valentina Romero-Fonnegra, Nicolas Cortes-Mejia, Diana Fernanda Bejarano-Ramirez, Valentina Maldonado-Hoyos, Sandra Janeth Sanchez-Garcia, Alonso Vera-Torres

Abstract read
In one paragraph

Article in Frontiers in transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rosana Cordoba-AlvaradoClinical Psychology Section, Transplant Services, Fundacion Santa Fe de Bogotá, Bogotá, Colombia.
Valentina Romero-FonnegraFaculty of Psychology, Universidad de los Andes, Bogotá, Colombia.
Nicolas Cortes-MejiaTransplant and Hepatobiliary Surgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Diana Fernanda Bejarano-RamirezTransplant and Hepatobiliary Surgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Valentina Maldonado-HoyosFaculty of Psychology, Universidad de los Andes, Bogotá, Colombia.
Sandra Janeth Sanchez-GarciaClinical Psychology Section, Transplant Services, Fundacion Santa Fe de Bogotá, Bogotá, Colombia.
Alonso Vera-TorresTransplant and Hepatobiliary Surgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Liver transplantation (LT) improves survival in end-stage liver disease. Several reports have addressed the impact of LT on patients' lives, beyond purely medical outcomes. Although the quality of life and mental health have been demonstrated to improve with this procedure, such studies are still missing in Latin America. Methods: Patients who received LT at the Fundación Santa Fe de Bogotá between 2017 and 2019 were assessed for quality of life (QoL), anxiety, and depression and they were followed up for one year after the procedure. Pre-transplant data were gathered at inclusion on the waiting list, while post-transplant data at 3- and 12 months after LT. European Quality of Life-5 Dimensions (EQ-5D) and European Quality of Life-Visual Analog Scale (EQ-VAS) instruments were used to evaluate QoL. The Hospital Anxiety and Depression Scale (HADS) was used for evaluating anxious and depressive symptoms. Results: 115 recipients met the inclusion criteria. Mean pre-transplant EQ-VAS was 70.78, rising to 87.16 and 92.56 at 3- and 12-months, respectively. Improvements in all EQ-5D dimensions were found in response to LT. According to the HADS questionnaire, anxiety was reduced by 2.35 points and depression by 1.63 points after LT. Conclusion: in the short term, LT is a successful strategy for enhancing QoL, anxiety, and depression in patients with liver disease. Long-term benefits must be assessed.

Indexed as

European Quality of Life-5 Dimensions (EQ-5D)European Quality of Life Visual Analog Scale (EQ-VAS)Hospital Anxiety and Depression Scale (HADS)liver transplantation (LT)quality of life

Identifiers

PMID39640493
PMCPMC11617532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.